Michael Halassa
Substacknewsletter · by Michael Halassa · English
Michael M. Halassa, MD, PhD is a Professor of Neuroscience and Psychiatry whose work has redefined the role of the thalamus in cognition. His clinical focus is on schizophrenia and related disorders.
- Audience
- 2K subscribers
- Shown publicly on Substack
- Publishing
- Every two weeks
- 5 posts indexed in the last 90 days
- Last post
- Oct 9, 2026
- 21 days ago
- Likely audience
- cognitive scientists
- Inferred from post content
Michael Halassa is a Substack newsletter by Michael Halassa covering Clinical trial results, Long-acting injectable antipsychotics and Psychiatric medication adherence. NewsletterFIT indexed 5 posts from it in the last 90 days, most recently on Oct 9, 2026. Shown publicly on Substack: 2K subscribers.
Topics
- Clinical trial results
- Long-acting injectable antipsychotics
- Psychiatric medication adherence
- Post-injection delirium/sedation syndrome
- Drug formulation technology
Recent posts
- Will Olanzapine…
- Why is…
- Is There…
- Well, That…
- The brain…
Sponsors detected
No sponsored posts detected in the last 180 days of indexed posts.
Detected automatically from posts marked as sponsored. Detection can miss or misread placements.
See the full picture on Michael Halassa
Subscriber momentum over time, every detected sponsor with the source post, companies and people it mentions, guests, and an alert when any of it changes.
Similar newsletters
Ranked by how many topics they share with Michael Halassa.
- Dr. Michael Okun on Parkinson's & Brain Health11K subscribers
SubstackMonthly or less · last post 18 days ago
Likely audience: Patients with Parkinson's disease
1 shared topic
LinkedInEvery two weeks · last post 8 days ago
Likely audience: Healthcare investors
1 shared topic
Compiled from public pages · refreshed Oct 22, 2026 · How NewsletterFIT collects and labels data
